Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.

PHASE3CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

April 19, 2019

Primary Completion Date

April 5, 2023

Study Completion Date

April 5, 2023

Conditions
Cardiogenic Shock
Interventions
COMBINATION_PRODUCT

Hydrocortisone + Flucortac

Low dose steroids

OTHER

Placebo

Placebo

Trial Locations (21)

30029

CHU de Nîmes, Nîmes

31400

Hopital Rangueil, Toulouse

34090

Hôpital Arnaud-de-Villeneuve, Montpellier

37000

CHRU Hôpitaux de Tours, Tours

59000

CHU Lille - Institut Cœur Poumon, Lille

67000

CHU de Strasbourg, Strasbourg

69007

Centre Hospitalier Saint Joseph Saint Luc, Lyon

75013

Hôpitaux Universitaires Pitié Salpêtrière, Paris

75014

Groupe Hospitalier Paris Saint Joseph, Paris

Hôpital Cochin, Paris

75015

Hôpital européen Georges-Pompidou, Paris

75018

Hôpital Bichat, Paris

77600

CH de Marne la Vallée - Site Jossigny, Jossigny

78150

Hôpital Parly II, Le Chesnay

91300

Hôpital Privé Jacques Cartier, Massy

92100

Hôpital Ambroise Paré, Boulogne-Billancourt

92200

CMC Ambroise Paré, Neuilly-sur-Seine

93200

Centre cardiologique du nord saint denis, Saint-Denis

94190

CH Intercommunal de Villeneuve Saint Georges, Villeneuve-Saint-Georges

95300

CH Pontoise, Pontoise

Unknown

Hôpital Henri Mondor, Paris

All Listed Sponsors
lead

CMC Ambroise Paré

OTHER

NCT03773822 - Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock. | Biotech Hunter | Biotech Hunter